Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             199 results found
no title author magazine year volume issue page(s) type
1 A best fit regression analysis to predict dosimetric parameters in prostate brachytherapy using 131Cs given the impact of changing prostate edema Kehwar, Than S.
2009
8 2 p. 166
article
2 Accelerated partial breast irradiation for Asian women with Stage 0 or I breast cancer – A Phase II toxicity study Tang, Johann I.
2009
8 2 p. 140
article
3 Accelerated partial breast irradiation using balloon brachytherapy for ductal carcinoma in situ of the breast: A 5-year experience Prestidge, Bradley R.
2009
8 2 p. 107
article
4 A comparative clinical study and dosimetry planning experience with the new Contura™ multi-lumen versus MammoSite® single-lumen high-dose-rate balloon breast applicators under the RTOG 0413 protocol Morcovescu, Serban
2009
8 2 p. 136-137
article
5 A Comparison Between LDR and MRI Conformal HDR Brachytherapy of Cervical Cancer: Results, Patterns of Failure and Late Complications Bernshaw, David L.
2009
8 2 p. 111
article
6 A comparison of post-implant US/CT image fusion and MRI/CT image fusion for 125I prostate brachytherapy post implant dosimetry Patanjali, Nitya
2009
8 2 p. 124
article
7 A comparison of skin and chest wall dose delivered with multicatheter, Contura™ Multilumen Balloon, and MammoSite® breast brachytherapy Cuttino, Laurie W.
2009
8 2 p. 118
article
8 A comparison of the biological effective dose of 50 KV electronic brachytherapy to 192Ir high-dose-rate brachytherapy for vaginal cuff irradiation Markelewicz, Robert J.
2009
8 2 p. 126-127
article
9 A comparison study of technique, limitations and clinical outcome of MammoSite® vs. SAVI for partial breast brachytherapy Youssef, Ashraf
2009
8 2 p. 139
article
10 A correlation of bladder and rectal point doses with 3-d volume-based treatment planning for intracavitary brachytherapy in the treatment of locally advanced cervical cancers Chatterjee, Koushik
2009
8 2 p. 143-144
article
11 Adjuvant high-dose-rate brachytherapy in adults with soft tissue sarcoma: A single institution experience Shultz, David B.
2009
8 2 p. 134
article
12 A dosimetric comparison of AccuBoost® noninvasive partial breast brachytherapy to electron beam tumor bed boost and 3-D conformal accelerated partial breast irradiation Sioshansi, Shirin
2009
8 2 p. 117
article
13 A dosimetric comparison of the model 6711 125I source and a new, smaller diameter brachytherapy seed (model 9011) using Monte Carlo methods Rivard, Mark J.
2009
8 2 p. 114
article
14 American Brachytherapy Society 2009 Annual Meeting Program 2009
8 2 p. 85-93
article
15 An evaluation of implant needle motion with high-dose-rate brachtherapy for prostate cancer Agustin, Jeffrey
2009
8 2 p. 167-168
article
16 An investigation of effective optimization algorithm for ultrasound based real time high-dose-rate brachytherapy for the prostate Pokharel, Shyam
2009
8 2 p. 155-156
article
17 A novel approach to manage gastric adenocarcinoma Hariri, Sanaz
2009
8 2 p. 158-159
article
18 A novel brachytherapy source and delivery system for use in conjunction with VATS wedge resection of early-stage lung cancer Wazer, David E.
2009
8 2 p. 133-134
article
19 A preliminary quality of life assessment of genitourinary and gastrointestinal toxicity comparing two fractions versus four fractions high dose radiation alone in early prostate cancer patients McPhee, Kathleen A.
2009
8 2 p. 119
article
20 A prospective randomized study to compare the short-term urinary function between silodosin and tamsulosin after 125I prostate brachytherapy Ikeda, Tetsuhiro
2009
8 2 p. 170
article
21 A report on the initial experience with the Mick CT-compatible high-dose-rate split ring applicator® Juliano, Justin J.
2009
8 2 p. 129
article
22 A retrospective comparison of vaginal brachytherapy alone vs. brachytherapy and external beam therapy as adjuvant treatment for intermediate-risk endometrial cancer Feldmeier, John J.
2009
8 2 p. 143
article
23 A semi-automatic segmentation method for prostate boundary delineation Mahdavi, Seyedeh Sara
2009
8 2 p. 175
article
24 Association between erectile function and lower urinary tract symptoms in patients treated with permanent seed prostate brachytherapy Taussky, Daniel
2009
8 2 p. 170-171
article
25 Author Index, 30th Annual Meeting of the American Brachytherapy Society 2009
8 2 p. 265-267
article
26 Automated 2D/3D registration algorithm for high-dose-rate lung brachytherapy Zvonarev, Pavel S.
2009
8 2 p. 129-130
article
27 Bilateral perineural invasion on prostate biopsy significantly lowers five year cancer free survival in patients treated with prostate brachytherapy Shanahan, Thomas G.
2009
8 2 p. 178
article
28 Brachytherapy dosimetry simulation of eye physics slotted plaque: A Monte Carlo study Owrangi, Amir M.
2009
8 2 p. 131
article
29 Brachytherapy treatment planning for complex applicators based on the AAPM TG-43 dosimetry algorithm: Case studies and clinical impact Rivard, Mark J.
2009
8 2 p. 106
article
30 Classification of rectal complications using the Expanded Prostate Cancer Index Composite: Correlation with dose depends on interpretation of the scores Tack, Krystina M.
2009
8 2 p. 164-165
article
31 Clinical and dosimetric variables associated with acute bowel toxicity following prostate seed brachytherapy with 131Cs Gokhale, Abhay S.
2009
8 2 p. 170
article
32 Clinical experience with GAF chromic film for dose measurements in high-dose-rate brachytherapy surface applicator (Leipzig) treatments: Phantom and patient results Gary Kuo, Hsiang-Chi
2009
8 2 p. 153
article
33 Clinical feasibility of multiple outpatient high-dose-rate brachytherapy insertions through a cervical sleeve and three-dimensional dosimetry for inoperable endometrial cancer Mehta, Keyur
2009
8 2 p. 141
article
34 Clinical impact of dose volume adaptation and dose escalation in MRI-guided high-dose-rate brachytherapy including the use of combined intracavitary/interstitial techniques for patients with poor response cervical cancer FIGO stage IIB or IIIB Sturdza, Alina E.
2009
8 2 p. 113
article
35 C4 MRI ECAMS have no effect on 125I seed anisotropy and are visibile after radiaton exposure Frank, Steven J.
2009
8 2 p. 172
article
36 Comparative study of permanent interstitial prostate brachytherapy post-implant evaluation among two North American institutes Balbontin, Felipe G.
2009
8 2 p. 179
article
37 Comparison of CT and MRI cervical cancer brachytherapy target and normal tissue volumes Eskander, Ramez N.
2009
8 2 p. 111-112
article
38 Comparison of CT vs. ultrasound to determine prostate volume prior to real-time ultrasound based intraoperative planning for 125I seed implantation Fogh, Shannon E.
2009
8 2 p. 176
article
39 Comparison of heart dose of external beam therapy and multi-channel high-dose-rate breast applicators Axelrod, Steve
2009
8 2 p. 152
article
40 Comparison of outcomes of lung cancer patients treated with surgical resection with 125I lung brachytherapy vs stereotactic hypofractionated radiation therapy for single lung lesions Parashar, Bhupesh
2009
8 2 p. 159-160
article
41 Comparison of tumor control outcomes and toxicity between LDR brachytherapy and high dose IMRT for clinically localized prostate cancer Zelefsky, Michael J.
2009
8 2 p. 105
article
42 Cone beam computed tomography as a way to assess and reduce the dosimetric impact of interfraction catheter displacement in prostate high-dose-ratebrachytherapy Foster, William
2009
8 2 p. 167
article
43 Contura™ multi-lumen radiation balloon brachytherapy applicator: A potential advantage for patients with early breast cancer Ghaly, Maged
2009
8 2 p. 137
article
44 Correlation between low dose hyper-radiosensitivity and low-dose-rate hyperradiosensitivity from the “inverse” dose rate effect – Potential influence in low-dose-rate brachytherapy Leonard, Bobby E.
2009
8 2 p. 156
article
45 Counterpoint: Conformal external beam for accelerated partial breast irradiation Taghian, Alphonse G.
2009
8 2 p. 184-188
article
46 CT simulation as a pretreatment quality assurance tool for elliptical MammoSite® balloons Doyle, Laura
2009
8 2 p. 135-136
article
47 Curvilinear brachytherapy source characterization in a conventional treatment planning system using the AAPM TG-43 polar coordinate system Bannon, Elizabeth A.
2009
8 2 p. 147
article
48 Definitive radiation therapy for endometrial cancer in medically-inoperable elderly patients Wegner, Rodney E.
2009
8 2 p. 142-143
article
49 Description and predictive factors of urinary toxicity following prostate brachytherapy using 131Cs Smith, Ryan P.
2009
8 2 p. 172-173
article
50 Determination of the dosimetric characteristics of a new polymer-encapsulated, elongated, 103Pd brachytherapy source using Monte Carlo calculations Paxton, Adam B.
2009
8 2 p. 149-150
article
51 Development of super miniature x-ray tube for brachytherapy using carbon nanotube field emitters Heo, Sunghwan
2009
8 2 p. 149
article
52 Does equivalent uniform dose affect toxicity for high-dose-rate brachytherapy using the MammoSite® applicator? Stewart, Alexandra J.
2009
8 2 p. 138
article
53 Does treatment time or source strength affect late toxicity in accelerate partial breast irradiation brachytherapy? Heffernan, Jill
2009
8 2 p. 118-119
article
54 Dose calculations around elongated curved brachytherapy sources Aryal, Prakash
2009
8 2 p. 148
article
55 Dose escalation to the dominant intraprostatic lesion defined by sextant biopsy in a permanent prostate 125I implant: A prospective comparative dosimetric and toxicity analysis Gaudet, Marc
2009
8 2 p. 177-178
article
56 Dose escalation with high-dose 3D-conformal radiotherapy (HD-3D-CRT) or low-dose 3D-conformal radiotherapy plus HDR brachytherapy (LD-3D-CRT+HDR-B) for intermediate- or high-risk prostate cancer: Early results of a prospective comparative trial Guix, Benjamin
2009
8 2 p. 105-106
article
57 Dosimetric analysis of biochemical outcome following 125I permanent prostate brachytherapy Stephans, Kevin L.
2009
8 2 p. 169
article
58 Dosimetric analysis of 3D image-guided high-dose-rate brachytherapy planning for the treatment of cervical cancer Kim, Hayeon
2009
8 2 p. 127
article
59 Dosimetric characteristics of a 32P film source for surface irradiation Munro III, John J.
2009
8 2 p. 151
article
60 Dosimetric characterization of the thermobrachytherapy surface applicator Craciunescu, Oana I.
2009
8 2 p. 157-158
article
61 Dosimetric effect of interfractional catheter displacement in prostate high-dose-rate brachytherapy Kovalchuk, Nataliya
2009
8 2 p. 114-115
article
62 Dosimetric evaluation of internal shielding in a high-dose-rate skin applicator Lliso, Francoise
2009
8 2 p. 150-151
article
63 Dosimetric investigation of a 90Sr/90Y source for intra-ocular treatment of age-related wet macular degeneration Holmes, Shannon M.
2009
8 2 p. 132
article
64 Dosimetric measurements of a new electronic brachytherapy surface applicator Axelrod, Steve
2009
8 2 p. 151-152
article
65 Dosimetric study of permanent prostate brachytherapy utilizing 131Cs, 125I and 103Pd seeds Yang, Ruijie
2009
8 2 p. 156
article
66 Early mortality after treatment for localized prostate cancer Reddy, Chandana A.
2009
8 2 p. 160
article
67 Editorial Board 2009
8 2 p. A1
article
68 Effect of prostate-specific antigen bounce on outcome in patients treated with permanent 125I-seed prostate brachytherapy Zwahlen, Daniel R.
2009
8 2 p. 161
article
69 Effects of 3-month neoadjuvant hormonal therapy before permanent seed implant brachytherapy on disease-specific and global health related quality of life, urinary complaints and prostate-specific antigen course Davits, Rob
2009
8 2 p. 163-164
article
70 Erectile function durability following permanent prostate brachytherapy Taira, Al V.
2009
8 2 p. 168
article
71 Evaluation of different inverse planning algorithms for high-dose-rate prostate brachytherapy Sangalli, Giulia
2009
8 2 p. 148-149
article
72 Evaluation of long-term bowel and urinary toxicity after permanent prostate brachytherapy Stephans, Kevin L.
2009
8 2 p. 120
article
73 Evaluation of methods of interpolation-extrapolation of gL(r) and F(r,θ) for high-energy brachytherapy sources Pujades-Claumarchirant, M. Carmen
2009
8 2 p. 131-132
article
74 Evidence of a urinary flare and a prostate-specific antigen bounce in a multi-institutional 131Cs monotherapy trial Prestidge, Bradley R.
2009
8 2 p. 174
article
75 Experimental determination of the dose perturbation to clinically defined bladder and rectal points for a shielded intracavitary tandem & ovoid applicator in high-dose-rate brachytherapy Stanley, Thomas R.
2009
8 2 p. 122-123
article
76 Factors impacting all cause mortality in men receiving androgen deprivation therapy with prostate brachytherapy Taira, Al V.
2009
8 2 p. 165-166
article
77 Factors predicting prostate gland shrinkage following neoadjuvant cytoreductive therapy Merrick, Gregory S.
2009
8 2 p. 165
article
78 Feasibility and early outcomes (toxicities, cosmesis) of accelerated partial breast irradiation with MammoSite® balloon delivery system in patients with early stage breast cancer Desai, Gopal R.
2009
8 2 p. 140-141
article
79 Feasibility of marker-catheters for a titanium tandem and ovoids applicator in MRI-guided bracytherapy: Implications on applicator reconstruction on 3 Tesla MRI Kim, Yusung
2009
8 2 p. 121
article
80 Five-year results of accelerated partial breast irradiation for ductal carcinoma in situ treated by interstitial multicatheter high-dose-rate brachytherapy or MammoSite® Adkison, Jarrod B.
2009
8 2 p. 107-108
article
81 Guide for Authors 2009
8 2 p. A7
article
82 145 Gy vs. 160 Gy for a prescription dose: A comparison of dosimetry and acute toxicity in 125I permanent implant for prostate cancer Yorozu, Atsunori
2009
8 2 p. 160-161
article
83 High-dose-rate brachyhterapy as a boost for carcinoma of the oral tongue Akl, Ahmed M.
2009
8 2 p. 159
article
84 High-dose-rate brachytherapy as monotherapy delivered in two fractions over one day for favorable-risk prostate cancer. Preliminary toxicity data Ghilezan, Michel
2009
8 2 p. 176
article
85 High-dose-rate brachytherapy for cervix carcinoma using the Nice gynecologic applicator: A new procedure combining endocavitary and interstitial approach Hannoun-Levi, Jean-Michel
2009
8 2 p. 128-129
article
86 High-dose-rate brachytherapy source tracking by MOSFET dosimetry system Ivanova, Tatjana
2009
8 2 p. 130
article
87 High-dose-rate interstitial brachytherapy for previously untreated cervical carcinoma Isohashi, Fumiaki
2009
8 2 p. 234-239
article
88 High-dose-rate intracavitary brachytherapy in locally advanced uterine cervix cancer using three different fractionation schedules: An Indian experience Kundu, Sayan
2009
8 2 p. 111
article
89 High-dose-rate prostate brachytherapy and supplemental external beam radiotherapy: A comparison of single fraction 15Gy high-dose-rate and hypofractionated external beam to a conventional fractionated regimen Morton, Gerard C.
2009
8 2 p. 110
article
90 High-dose-rate salvage treatment of prostate-specifc antigen only recurrent prostate cancer after radical prostatectomy: A feasibility study in 5 patients Mark, Rufus J.
2009
8 2 p. 164
article
91 Higher rate of prostate-specific antigen bounce ≥2 ng/mL with brachytherapy in young prostate cancer patients Park, Sean
2009
8 2 p. 172
article
92 1H-MR spectroscopic imaging of prostate pre- and post-brachytherapy: Present and future Damyanovich, Andrei
2009
8 2 p. 166-167
article
93 Hormonal blockade for salvage treatment of prostate-specific antigen only recurrent prostate cancer after interstitial high-dose-rate brachytherapy for early stage prostate cancer: long-term followup in 23 patients Mark, Rufus J.
2009
8 2 p. 164
article
94 125I brachytherapy as monotherapy in patients aged ≤55 years with localized prostate cancer Gomez-Iturriaga, Alfonso
2009
8 2 p. 120
article
95 Image fusion of prostate preplan transrectal ultrasound and post 125I-seed implant ct images to improve consistency and accuracy of post-seed implant quality statistics Smith, Ryan L.
2009
8 2 p. 116
article
96 Image-guided intracavitary high-dose-rate brachytherapy for cervix cancer: A single institutional experience with three-dimensional CT-based planning Wang, Brian
2009
8 2 p. 240-247
article
97 Imaging technologies for cervical cancer brachytherapy: a systematic review D'Souza, David P.
2009
8 2 p. 143
article
98 Impact of age on biochemical control in a cohort of intermediate- and high-risk prostate cancer patients treated with high-dose-rate brachytherapy boost combined with pelvic external beam radiation therapy Limbacher, Amy L.
2009
8 2 p. 174
article
99 Impact of transrectal ultrasound- and computed tomography-based seed localization on postimplant dosimetry in prostate brachytherapy Chew, Meng-Sang
2009
8 2 p. 255-264
article
100 Influence of isotope selection on morbidity of external beam radiotherapy with low-dose-rate boost for prostate cancer Chino, Junzo P.
2009
8 2 p. 175-176
article
101 Initial clinical experience with a single entry multichannel brachytherapy device, SAVI, for accelerated partial breast irradiation Yashar, Catheryn M.
2009
8 2 p. 116-117
article
102 Initial dosimetric experience: Contura™ Multilumen Balloon Registry Trial Arthur, Douglas W.
2009
8 2 p. 117-118
article
103 Initial radiation experience evaluating early tolerance and toxicities in patients undergoing accelerated partial breast irradiation using the Contura Multi-Lumen Balloon breast brachytherapy catheter Brown, Sheree
2009
8 2 p. 227-233
article
104 Inoperable endometrial carcinoma treated with definitive radiotherapy: Survival, local control, and treatment side effects Duncan, Casey
2009
8 2 p. 141
article
105 Interface dosimetry for electronic brachytherapy Xoft balloon applicators Segala, James
2009
8 2 p. 123-124
article
106 Interobserver study of countouringbased on ultrasound image in real-time interactive prostate brachytherapy Rodriguez, Silvia
2009
8 2 p. 173-174
article
107 Interstitial brachytherapy as boost for T4 locally advanced head and neck cancer Do, Ly V.
2009
8 2 p. 133
article
108 Interstitial high-dose-rate brachytherapy for breast cancer in women ≤50 years of age compared to >50 years of age. A report of 192 cases using multicatheter technique Mark, Rufus J.
2009
8 2 p. 139
article
109 Interstitial high-dose-rate brachytherapy for ductal carcinoma in situ of the breast: Median 5-year followup of 44 cases using multicatheter technique Mark, Rufus J.
2009
8 2 p. 137-138
article
110 Interstitial high-dose-rate brachytherapy for early stage breast cancer: Median 5-year followup of 192 cases using multicatheter technique Mark, Rufus J.
2009
8 2 p. 108-109
article
111 Interstitial high-dose-rate brachytherapy + intensity modulated radiation therapy vs. high-dose-rate monotherapy for early stage prostate cancer: Median 7-year followup in 380 cases Mark, Rufus J.
2009
8 2 p. 109
article
112 Inverse-planned image-guided robotic brachytherapy: Preclinical proofs of principle Cunha, J. Adam M.
2009
8 2 p. 115-116
article
113 In vivo dose measurements for high-dose-rate brachytherapy using a new scintillating fiber dosimetry system: A prostate phantom study Therriault-Proulx, Francois
2009
8 2 p. 115
article
114 Iris melanoma brachytherapy treatment using modified COMS plaque Kovalchuk, Nataliya
2009
8 2 p. 150
article
115 Japanese clinical outcome in patients with locally and locally advanced prostate cancer treated with high-dose-rate brachytherapy Jo, Yoshimasa
2009
8 2 p. 169-170
article
116 Listing of Plenary, Oral and Poster Presentations of the 30th Annual Meeting of the American Brachytherapy Society 2009
8 2 p. 94-104
article
117 Loading pattern calculated by inverse optimization vs traditional dosimetry systems of intracavitary brachytherapy of cervical cancer – A dosimetric study Swamidas, Jamema V.
2009
8 2 p. 127-128
article
118 Logistics of tandem and ovoids HDR plan optimization in MRI-guided brachytherapy for cervical cancer: Comparisons of standard, graphical, and inverse optimizations Kim, Yusung
2009
8 2 p. 121-122
article
119 Long-term outcome of MRSI-directed dose escalation for prostate brachytherapy Yuen, Jasper
2009
8 2 p. 168
article
120 Long-term results of the German-Austrian phase II study – accelerated partial breast irradiation using multicatheter brachytherapy for early breast cancer Strnad, Vratislav
2009
8 2 p. 107
article
121 Masthead 2009
8 2 p. A2
article
122 Maximal 3-D dose to the whole bladder versus bladder wall in image-guided high-dose-rate intracavitary brachytherapy planning with bladder distension for cervical cancer Monaghan, M.
2009
8 2 p. 142
article
123 Monte Carlo dosimetry for 125I and 103Pd eye plaque brachytherapy with various seed models Thomson, Rowan M.
2009
8 2 p. 130-131
article
124 Monte Carlo inverse planning in high-dose-rate brachytherapy: The impact of source energy spectra on heterogeneities and boundaries D'Amours, Michel
2009
8 2 p. 145-146
article
125 Monte Carlo simulations and radiation dosimetry measurements of peripherally-applied high-dose-rate 192Ir breast brachytherapy D-shaped applicators Yang, Yun
2009
8 2 p. 134-135
article
126 Morbidity and prostate-specific antigen control of external beam radiation therapy plus low-dose-rate brachytherapy boost for low, intermediate, and high-risk prostate cancer Koontz, Bridget F.
2009
8 2 p. 191-196
article
127 MRI-guided high-dose-rate intracavitary brachytherapy in cervical cancers at Tata Memorial Hospital: The initial clinical outcome Mahantshetty, Umesh M.
2009
8 2 p. 112
article
128 Multi-image fusions and their role in inverse planned high-dose-rate prostate brachytherapy for dose escalation of dominant intraprostatic lesions defined by combined MRI/MRSI Pouliot, Jean
2009
8 2 p. 113-114
article
129 Obesity does not predict Gleason score, tumor location or cancer volume following transperineal template-guided prostate mappy biopsy Allen, Zachariah A.
2009
8 2 p. 173
article
130 Oncentra brachy commissioning Frigerio, Cristina
2009
8 2 p. 147-148
article
131 One-year results of 125I vs. 131Cs prospective randomized trial on urinary function following prostate brachytherapy Moran, Brian J.
2009
8 2 p. 109-110
article
132 On the impacts of the uncertainty of tissue chemical composition on dose distribution for breast low-dose-rate brachytherapy Afsharpour, Hossein
2009
8 2 p. 146
article
133 Outcomes in patients with HER2 overexpressing and triple negative phenotypes treated with partial breast irradiation using MammoSite® brachytherapy Sharma, Neha
2009
8 2 p. 139-140
article
134 Outcomes of high dose rate interstitial boost brachytherapy after external beam radiation therapy in head and neck cancer—An Indian (single institutional) learning experience Patra, Niladri B.
2009
8 2 p. 248-254
article
135 Partial breast irradiation and cardiac dose Benda, Rashmi
2009
8 2 p. 116
article
136 Peak flow rate is the best predictor of acute urinary retention following low-dose-rate brachytherapy Ikeda, Tetsuhiro
2009
8 2 p. 162-163
article
137 Permanent prostate brachytherapy in prostate glands less than 20 cm3 Mayadev, Jyoti
2009
8 2 p. 119-120
article
138 Permanent prostate brachytherapy preplanned technique: The modern Seattle method step-by-step and dosimetric outcomes Sylvester, John E.
2009
8 2 p. 197-206
article
139 Point: Brachytherapy for accelerated partial breast irradiation Wazer, David E.
2009
8 2 p. 181-183
article
140 Post-implant rectal dosimetry is not dependent on 103Pd or 125I seed activity Merrick, Gregory S.
2009
8 2 p. 125
article
141 Preoperative endorectal high-dose-rate brachytherapy: Pathologic downstaging in locally advanced rectal cancer Ghaly, Maged
2009
8 2 p. 133
article
142 Previous transurethral resection of the prostate is not a contraindication for interstitial high-dose-rate brachytherapy for prostate cancer Mark, Rufus J.
2009
8 2 p. 160
article
143 Prospective evaluation of erectile function using International Index of Erectile Function score after 125I permanent prostate brachytherapy Patil, Nikhilesh G.
2009
8 2 p. 171
article
144 Prostate brachytherapy biochemical relapse-free survival outcomes in intermediate-risk prostate cancer patients Sylvester, John E.
2009
8 2 p. 176-177
article
145 Prostate-specific antigen bounce after external beam radiotherapy plus high-dose-rate brachytherapy boost for definitive management of localized prostate cancer Peddada, Anuj V.
2009
8 2 p. 178-179
article
146 PSA kinetics >5 years after treatment with brachytherapy or external beam radiotherapy: Defining the long-term PSA profile for biochemical control Ciezki, Jay P.
2009
8 2 p. 120-121
article
147 Pulmonary seed embolization after transperineal interstitial prostate brachytherapy: Does small prostate gland or seed placement outside the prostate capsule increase frequency of seed loss? Yousuf, Junaid
2009
8 2 p. 171-172
article
148 Quadrant dosimetry as a predictor of biochemical relapse in 125I prostate brachytherapy Spadinger, Ingrid
2009
8 2 p. 126
article
149 RACS, MACS and LCDS: How to work with them and understand how they affect your practice DiGiaimo, Ron
2009
8 2 p. 156-157
article
150 Radioactive seed strand migration after prostate brachytherapy Tuanquin, Leonard C.
2009
8 2 p. 162
article
151 Randomized trial comparing intra-operative flexible, regid and no cystoscopy after prostate brachytherapy Sylvester, John E.
2009
8 2 p. 168-169
article
152 Rebuttal to Drs. Taghian and Bourgier Wazer, David E.
2009
8 2 p. 190
article
153 Rebuttal to Dr. Wazer Taghian, Alphonse G.
2009
8 2 p. 189
article
154 Rectal injury doses from permanent prostate brachytherapy Bice, William S.
2009
8 2 p. 124-125
article
155 Results of preoperative endocavitary brachytherapy in Stage IB cervical carcinoma Coza, Ovidiu
2009
8 2 p. 144
article
156 Risk factors for axillary failure in patients with early stage breast cancer managed with accelerated partial breast irradiation using the MammoSite® breast brachytherapy catheter Aburabia, Majd A.
2009
8 2 p. 107
article
157 Robotically-assisted minimally invasive brachytherapy: A series of porcine trials Godfrey, Loren
2009
8 2 p. 157
article
158 Salvage high-dose-rate brachytherapy for locally recurrent prostate cancer following primary external beam radiation therapy: Early toxicity results of a prospective study Kollmeier, Marisa A.
2009
8 2 p. 119
article
159 SAVI breast brachytherapy device allows expansion of women eligible for accelerated partial breast irradiation to whose with small breasts and narrow skin bridges Scanderbeg, Daniel J.
2009
8 2 p. 124
article
160 Seed immobilization technique using laser coagulation for brachytherapy procedure Yan, Kaiguo
2009
8 2 p. 163
article
161 Seroma is an expected consequence and not a complication of MammoSite® brachytherapy Patel, Priti S.
2009
8 2 p. 108
article
162 Sexual outcomes unaffected by penile bulb dose in prostate brachytherapy Whaley, Jonathan T.
2009
8 2 p. 173
article
163 Shrinking the prostate with hormones: Effect on bichemical survival with prostate brachytherapy Thompson Jr., William R.
2009
8 2 p. 177
article
164 Skin and chest wall dose with multi-catheter and MammoSite breast brachytherapy: Implications for late toxicity Cuttino, Laurie W.
2009
8 2 p. 223-226
article
165 Sleeved seeds decrease gastrointestinal and genitourinary toxicity profiles in real-time intraoperatively planned permanent 125I implants Sharma, Navesh K.
2009
8 2 p. 179-180
article
166 Sleeved seeds decrease post-implant hotspots in real-time intraoperatively planned permanent 125I prostate implants Cohen, Randi J.
2009
8 2 p. 179
article
167 Spatial distribution and DVH parameters correlation of additional rectal/sigmoid mucosal points, in high-dose-rate intracavitary brachytherapy for carcinoma of the cervix – A dosimetric study Tiwana, Manpreet Singh
2009
8 2 p. 128
article
168 Systematic comparison of two methods of bladder contouring in cervix cancer brachytherapy: “Direct” vs. “indirect” Shenfield, Carey B.
2009
8 2 p. 141-142
article
169 Table of Contents 2009
8 2 p. A4-A5
article
170 Technique for quantifying balloon shape and results of a consistency evaluation Axelrod, Steve
2009
8 2 p. 152-153
article
171 Ten-year results in 1577 intermediate/high risk prostate cancer patients treated with external beam radiation therapy and hypofractionated high-dose-rate brachytherapy boost Martinez, Alvaro A.
2009
8 2 p. 109
article
172 TG-43U1-based dosimetric characterization of model 67-6520 137Cs brachytherapy source Meigooni, Ali S.
2009
8 2 p. 131
article
173 The design and dosimety of a four-channel cylinder for treatment of endometrial cancer with high-dose-rate brachytherapy using the varisource afterloader Hunter, Robert J.
2009
8 2 p. 154-155
article
174 The effect of obesity on rectal dosimetry after permanent prostate brachytherapy Patil, Nikhilesh
2009
8 2 p. 218-222
article
175 The impact of perineural invasion on biochemical outcome following permanent prostate 125I brachytherapy Gomez-Iturriaga, Alfonso
2009
8 2 p. 174-175
article
176 The importance of internal, endoscopically placed fiducials and three dimensional treatment planning in esophageal brachytherapy Koyfman, Shlomo A.
2009
8 2 p. 158
article
177 The miniSAVI multicatheter accelerated partial breast irradiation applicator and its use in patients with small lumpectomy cavities and/or inadequate skin distance: Early clinical experience Morcovescu, Serban
2009
8 2 p. 138
article
178 The necessity of systematic verification of applicator position in brachytherapy treatment of the vaginal cuff Rodriguez, Silvia
2009
8 2 p. 144-145
article
179 The role of androgen deprivation therapy in high-risk prostate cancer with Gleason score 8-10 and prostate-specific antigen ≤15 treated with permanent interstitial brachytherapy Fang, L. Christine
2009
8 2 p. 165
article
180 The role of dose escalation with intracavitary brachytherapy in the treatment of localized central nervous system malignancies: Long-term followup of outcomes and toxicities of a prospective study Wernicke, A. Gabriella
2009
8 2 p. 132-133
article
181 Time course of prostatic edema post permanent seed implant determined by magnetic resonance imaging Sloboda, Ron
2009
8 2 p. 126
article
182 Transperineal injection of hyaluronic acid in the anterior perirectal fat to decrease rectal toxicity from radiation delivered with low-dose-rate brachytherapy for prostate cancer patients Prada, Pedro J.
2009
8 2 p. 210-217
article
183 Treatment of locally advanced vaginal cancer with radio-chemotherapy and MRI-guided brachytherapy: Clinical feasibility and first results Rottenfusser, Andrea
2009
8 2 p. 112-113
article
184 Treatment parameters associated with acute and late toxicity in patients receiving accelerated partial breast irradiation using the MammoSite® brachytherapy device Kaufman, Isaac
2009
8 2 p. 138-139
article
185 Treatment planning considerations for electronic brachytherapy vaginal cylinder applicators Hiatt, Jessica R.
2009
8 2 p. 153-154
article
186 Ultrasound elastography – an image guidance tool for prostate brachytherapy Salcudean, Septimiu E.
2009
8 2 p. 125-126
article
187 Unexpected toxicity in a patient treated with 3D conformal accelerated partial breast radiotherapy Gupta, Sonia
2009
8 2 p. 207-209
article
188 Update of the 131Cs monotherapy trial: Comparison of early urethral symptoms between cesium and iodine Prestidge, Bradley R.
2009
8 2 p. 161-162
article
189 Use of optically stimulated luminescence dosimeters for in vivo dosimetry in high-dose-rate gynecological patients Sharma, Renu
2009
8 2 p. 155
article
190 Variability in Point A dosimetry for tandem and ring applications Wilkinson, Douglas A.
2009
8 2 p. 155
article
191 Variance in bladder and rectal doses in the course of fractionated vaginal cylinder high-dose-rate brachytherapy Yaparpalvi, Ravindra
2009
8 2 p. 145
article
192 Variations in Monte Carlo simulations of air kerma strength and impact on delivered dose Melhus, Christopher S.
2009
8 2 p. 146-147
article
193 Verification of balloon rotation for the Contura™ multilumen device for accelerated partial breast irradiation Ouhib, Zoubir
2009
8 2 p. 123
article
194 Verification of low-dose-rate brachytherapy theraputic gain or excess complications from hyperradiosensitivity from low-dose-rate “inverse” dose rate effect Lucas, Arthur C.
2009
8 2 p. 157
article
195 What is the optimal insertion angle of MammoSite® balloon in partial breast brachytherapy? A dosimetric point of view Gao, Mingcheng
2009
8 2 p. 137
article
196 Whole pelvic radiotherapy in combination with transperineal interstitial brachytherapy: Does coverage of the pelvic lymph nodes improve treatment outcome in high-risk prostate cancer? Bittner, Nathan
2009
8 2 p. 110-111
article
197 X-ray target composed of miniaturized structures for brachytherapy x-ray tubes Ihsan, Aamir
2009
8 2 p. 151
article
198 10-year experience with 125I prostate brachytherapy at Princess Margaret Hospital Crook, Juanita M.
2009
8 2 p. 163
article
199 10-year results of interstitial needle-catheter brachytherapy for accelerated partial breast irradiation: Excellent control rates with minimal toxicities Chen, Peter Y.
2009
8 2 p. 105
article
                             199 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands